165 related articles for article (PubMed ID: 28693214)
21. Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance.
Jia W; Wang W; Ji CS; Niu JY; Lv YJ; Zhou HC; Hu B
Onco Targets Ther; 2016; 9():5133-42. PubMed ID: 27574454
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis.
Saentaweesuk W; Silsirivanit A; Vaeteewoottacharn K; Sawanyawisuth K; Pairojkul C; Cha'on U; Indramanee S; Pinlaor S; Boonmars T; Araki N; Wongkham C
Clin Chim Acta; 2018 Feb; 477():66-71. PubMed ID: 29217428
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.
Nuzzo PV; Rubagotti A; Zinoli L; Salvi S; Boccardo S; Boccardo F
BMC Cancer; 2016 Feb; 16():95. PubMed ID: 26872609
[TBL] [Abstract][Full Text] [Related]
24. State of serum markers for detection of cholangiocarcinoma.
Wongkham S; Silsirivanit A
Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
[TBL] [Abstract][Full Text] [Related]
25. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
[TBL] [Abstract][Full Text] [Related]
26. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.
Tummanatsakun D; Proungvitaya T; Roytrakul S; Limpaiboon T; Wongkham S; Wongkham C; Silsirivanit A; Somintara O; Sangkhamanon S; Proungvitaya S
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31454981
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones.
Meng ZW; Han SH; Zhu JH; Zhou LY; Chen YL
World J Surg; 2017 Mar; 41(3):835-843. PubMed ID: 27766397
[TBL] [Abstract][Full Text] [Related]
28. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
30. Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand.
Songthamwat M; Chamadol N; Khuntikeo N; Thinkhamrop J; Koonmee S; Chaichaya N; Bethony J; Thinkhamrop B
World J Surg Oncol; 2017 Sep; 15(1):176. PubMed ID: 28931405
[TBL] [Abstract][Full Text] [Related]
31. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
[TBL] [Abstract][Full Text] [Related]
32. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.
Cheng Q; Feng F; Zhu L; Zheng Y; Luo X; Liu C; Yi B; Jiang X
Sci Rep; 2015 Nov; 5():16103. PubMed ID: 26534789
[TBL] [Abstract][Full Text] [Related]
33. Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma.
Zhou Q; Gong Y; Huang F; Lin Q; Zeng B; Li Z; Chen R
Dig Surg; 2013; 30(4-6):309-16. PubMed ID: 24008372
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
[TBL] [Abstract][Full Text] [Related]
35. Expression levels of serum miRNA-195 in different types of patients with cholangiocarcinoma and its value to determine the prognosis thereof.
Chen Q; Wang C; Zhang H; Li Y; Cao Y; Zhang Y; Liu S; Li Z; Xin X; Han X
Oncol Lett; 2018 Apr; 15(4):5947-5951. PubMed ID: 29552225
[TBL] [Abstract][Full Text] [Related]
36. LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma.
Jiang XM; Li ZL; Li JL; Zheng WY; Li XH; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1242-1247. PubMed ID: 28387907
[TBL] [Abstract][Full Text] [Related]
37. High Levels of Serum IgG for
Titapun A; Luvira V; Srisuk T; Jareanrat A; Thanasukarn V; Thanee M; Sa-Ngiamwibool P; Padthaisong S; Duangkumpha K; Suksawat M; Loilome W; Sithithaworn P; Techasen A; Thinkhamrop B; Dzienny A; Caglayan A; Park D; Mahmud S; Khuntikeo N
Int J Gen Med; 2021; 14():2191-2204. PubMed ID: 34103974
[TBL] [Abstract][Full Text] [Related]
38. Liver transplantation for intrahepatic cholangiocarcinoma.
Lee DD; Croome KP; Musto KR; Melendez J; Tranesh G; Nakhleh R; Taner CB; Nguyen JH; Patel T; Harnois DM
Liver Transpl; 2018 May; 24(5):634-644. PubMed ID: 29514406
[TBL] [Abstract][Full Text] [Related]
39. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
